Benzinga | May 6, 2021 08:14AM EDT

SVB Leerink Maintains Market Perform on Neurocrine Biosciences, Lowers Price Target to $100

SVB Leerink maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Market Perform and lowers the price target from $110 to $100.